BRIEF published on 03/13/2025 at 21:35, 1 year 3 months ago Relevant Gold Secures $8.5 Million in Private Placement Led by Kinross and Bollinger Private Placement Investor Rights Kinross Gold Wyoming Exploration William G. Bollinger
BRIEF published on 03/13/2025 at 21:35, 1 year 3 months ago Relevant Gold obtient 8,5 millions de dollars dans le cadre d'un placement privé mené par Kinross et Bollinger Placement Privé Droits Des Investisseurs Kinross Gold Exploration Du Wyoming William G. Bollinger
BRIEF published on 03/13/2025 at 21:33, 1 year 3 months ago Zomedica Announces Record Revenue and Strategic Growth in 2024 Veterinary Health Financial Stability 2024 Revenue Diagnostics Growth Equine Market
BRIEF published on 03/13/2025 at 21:33, 1 year 3 months ago Zomedica annonce un chiffre d'affaires record et une croissance stratégique en 2024 Santé Vétérinaire Stabilité Financière Chiffre D'affaires 2024 Diagnostic Croissance Marché Équin
BRIEF published on 03/13/2025 at 21:25, 1 year 3 months ago Fresh Vine Wine, Inc. Announces Rebranding to Amaze Holdings, Inc. Acquisition Rebranding NYSE American Creator Economy Amaze Software
BRIEF published on 03/13/2025 at 21:25, 1 year 3 months ago Fresh Vine Wine, Inc. annonce son changement de marque en Amaze Holdings, Inc. Acquisition Changement De Marque NYSE American Économie Des Créateurs Logiciel Amaze
BRIEF published on 03/13/2025 at 21:20, 1 year 3 months ago Kingstone Companies Reports Robust 2024 Financial Results Kingstone Companies Financial Results 2024 2025 Financial Guidance Direct Premiums Growth Combined Ratio Improvement
BRIEF published on 03/13/2025 at 21:20, 1 year 3 months ago Kingstone Companies publie de solides résultats financiers pour 2024 Kingstone Companies Résultats Financiers 2024 Orientations Financières 2025 Croissance Des Primes Directes Amélioration Du Ratio Combiné
BRIEF published on 03/13/2025 at 21:20, 1 year 3 months ago Jaguar Health Approves Proposals and Anticipates Key Developments in 2025 Crofelemer Clinical Trials Jaguar Health Regulatory Approval Rare Diseases
BRIEF published on 03/13/2025 at 21:20, 1 year 3 months ago Jaguar Health approuve les propositions et anticipe les développements clés en 2025 Crofelemer Jaguar Health Essais Cliniques Maladies Rares Approbation Réglementaire
Published on 06/27/2026 at 16:50, 23 hours 9 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 14 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 15 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 16 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 17 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day 15 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 15 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 16 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 16 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 16 hours ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
